Učitavanje...
Targeting Mutant KRAS in Pancreatic Cancer: Futile or Promising?
Pancreatic ductal adenocarcinoma (PDAC) is one of the most fatal cancers with a dismal prognosis for the patient. This is due to limited diagnostic options for the early detection of the disease as well as its rather aggressive nature. Despite major advances in oncologic research in general, the tre...
Spremljeno u:
| Izdano u: | Biomedicines |
|---|---|
| Glavni autori: | , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
MDPI
2020
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7459579/ https://ncbi.nlm.nih.gov/pubmed/32796566 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/biomedicines8080281 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|